Back to search

Angiogenesis-dependent diseases

Data up to Jan 2025

Published2001
Citations294
References35

Total Citations Per Year

Abstract

References (35)

Tumor Angiogenesis: Therapeutic Implications

1971 • 9,898 citations

Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma

1991 • 5,657 citations

Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth

1997 • 4,504 citations

Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma

1994 • 3,367 citations

Antitumor Activity of Thalidomide in Refractory Multiple Myeloma

1999 • 2,565 citations

Thalidomide is an inhibitor of angiogenesis.

1994 • 2,460 citations

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer.

2000 • 1,536 citations

Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.

2000 • 1,310 citations

Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy

2000 • 868 citations

Tumor Growth and Neovascularization: An Experimental Model Using the Rabbit Cornea 2

1974 • 762 citations

Bone marrow angiogenesis and progression in multiple myeloma

1994 • 656 citations

Bone Marrow Neovascularization, Plasma Cell Angiogenic Potential, and Matrix Metalloproteinase-2 Secretion Parallel Progression of Human Multiple Myeloma

1999 • 590 citations

Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia.

1997 • 546 citations

Peroxisome Proliferator-activated Receptor γ Ligands Are Potent Inhibitors of Angiogenesis in Vitro and in Vivo

1999 • 527 citations

Elevated Levels of an Angiogenic Peptide, Basic Fibroblast Growth Factor, in the Urine of Patients With a Wide Spectrum of Cancers

1994 • 478 citations

Hypoxic Induction of Endothelial Cell Growth Factors in Retinal Cells: Identification and Characterization of Vascular Endothelial Growth Factor (VEGF) as the Mitogen

1995 • 357 citations

Prognostic value of bone marrow angiogenesis in multiple myeloma.

2000 • 321 citations

Cellular Vascular Endothelial Growth Factor Is a Predictor of Outcome in Patients With Acute Myeloid Leukemia

1999 • 304 citations

Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis

2000 • 271 citations

Angiogenesis Research: Guidelines for Translation to Clinical Application

2001 • 262 citations

Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma

1999 • 252 citations

Bone Marrow in Polycythemia Vera, Chronic Myelocytic Leukemia, and Myelofibrosis Has an Increased Vascularity

2000 • 216 citations

The von Hippel-Lindau Tumor Suppressor Gene

2020 • 201 citations

Thalidomide in the Treatment of Relapsed Multiple Myeloma

2000 • 188 citations

Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells

1993 • 187 citations

Regulation of Angiogenesis

1997 • 187 citations

Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma

1999 • 156 citations

A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma

2000 • 124 citations

Combination Angiostatin and Endostatin Gene Transfer Induces Synergistic Antiangiogenic Activity in Vitro and Antitumor Efficacy in Leukemia and Solid Tumors in Mice

2001 • 116 citations

Angiogenesis in B Cell Lymphoproliferative Diseases. Biological and Clinical Studies

1995 • 106 citations

Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markers

2001 • 99 citations

Combination oral antiangiogenic therapy with thalidomide and sulindac inhibits tumour growth in rabbits

1998 • 77 citations

Successful treatment of multiple myeloma relapsing after high-dose therapy and autologous transplantation with thalidomide as a single agent

2000 • 51 citations

Low-dose of thalidomide in the treatment of refractory myeloma.

2000 • 25 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...
Angiogenesis-dependent diseases (2001) – Seminars in Oncology | Metascience Observatory Explorer